$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
雷莫芦单抗是肝癌的二线治疗药物吗?
2025-10-19 11:44:20
Check Details
患者用瑞格非尼治疗肝癌多久见疗效?
2025-10-19 11:44:20
Check Details
阿帕替尼是什么靶向药物?多少钱一盒?
2025-10-19 11:44:20
Check Details
雷莫芦单抗治疗肝细胞癌的作用靶点
2025-10-19 11:44:20
Check Details
瑞格非尼可用于曾经接受过索拉非尼(多吉美)治疗过的肝癌细胞患者
2025-10-19 11:44:20
Check Details
阿帕替尼对肝癌晚期有怎样的疗效?
2025-10-19 11:44:20
Check Details
雷莫芦单抗获美国FDA批准用于肝细胞癌患者的治疗
2025-10-19 11:44:20
Check Details
靶向药阿帕替尼列入医保了吗?
2025-10-19 11:44:20
Check Details
用瑞格菲尼治疗肝癌多久见效?
2025-10-19 11:44:20
Check Details
阿帕替尼可用于既往接受过至少一线系统性治疗后失败或不可耐受的晚期肝细胞癌患者
2025-10-19 11:44:20
Check Details
肝癌晚期适合使用瑞格菲尼吗?
2025-10-19 11:44:20
Check Details
肝细胞癌患者治疗新选择-雷莫芦单抗
2025-10-19 11:44:20
Check Details
1
2
...
2872
2873
2874
2875
2876
2877
2878
...
4160
4161
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas
2
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
3
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
4
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
5
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
6
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol
7
Lapatinib Side Effects: Managing Diarrhea, Skin Reactions, and Liver Function Changes
8
Cemiplimab: A PD-1 Checkpoint Inhibitor for Skin Cancers and Non-Small Cell Lung Cancer
9
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
10
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
11
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
12
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide